Education
About Us
Working with TipRanks
Follow Us
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
RESEARCH TOOLSreports
Total Valuation
Sun Pharmaceutical Industries Limited has a market cap or net worth of ₹4.00T. The enterprise value is ―.
Market Cap₹4.00T
Enterprise Value―
Share Statistics
Sun Pharmaceutical Industries Limited has 2,399,276,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,399,276,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sun Pharmaceutical Industries Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Sun Pharmaceutical Industries Limited is ―. Sun Pharmaceutical Industries Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Sun Pharmaceutical Industries Limited had revenue of 477.58B and earned 95.76B in profits. Earnings per share was 39.91.
Revenue477.58B
Gross Profit229.46B
Operating Income104.68B
Pretax Income110.88B
Net Income95.76B
EBITDA138.36B
Earnings Per Share (EPS)39.91
Cash Flow
In the last 12 months, operating cash flow was 25.10B and capital expenditures 0.00, giving a free cash flow of 25.10B billion.
Operating Cash Flow25.10B
Free Cash Flow25.10B
Free Cash Flow per Share10.46
Dividends & Yields
Sun Pharmaceutical Industries Limited pays an annual dividend of ₹5.5, resulting in a dividend yield of 0.93%
Dividend Per Share₹5.5
Dividend Yield0.93%
Payout Ratio10.27%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.67
52-Week Price Change15.33%
50-Day Moving Average1.73K
200-Day Moving Average1.77K
Relative Strength Index (RSI)44.68
Average Volume (3m)88.46K
Important Dates
Sun Pharmaceutical Industries Limited upcoming earnings date is Jul 31, 2025, TBA Not Confirmed.
Last Earnings DateMay 22, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend DateJul 07, 2025
Financial Position
Sun Pharmaceutical Industries Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Sun Pharmaceutical Industries Limited has paid 14.39B in taxes.
Income Tax14.39B
Effective Tax Rate―
Enterprise Valuation
Sun Pharmaceutical Industries Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Sun Pharmaceutical Industries Limited has ₹190.90B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹190.90B billion.
Cash & Marketable Securities₹190.90B
Total Debt₹0.00
Net Cash-₹190.90B
Net Cash Per Share-₹79.57
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Sun Pharmaceutical Industries Limited is ₹1,961.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,961.25
Price Target Upside14.03% Upside
Analyst ConsensusModerate Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast―